Back to User profile » Dr Ren-Ai Xu
Papers published by Dr Ren-Ai Xu:
Simultaneous Determination of Venetoclax and Posaconazole in Human Plasma by UPLC-MS/MS: Application to Therapeutic Drug Monitoring in Acute Myeloid Leukemia Patients
Chen X, Wu H, Fu H, Wang P, Cao L, Li R, Zhan R, Xu RA
Drug Design, Development and Therapy 2026, 20:537699
Published Date: 12 January 2026
Development and Validation of a UPLC-MS/MS Detection Method of Baricitinib for Therapeutic Drug Monitoring in COVID-19 Patients
Zhan R, Shen Y, Fu H, Wu H, Chen X, Yu Y, Xu RA
Drug Design, Development and Therapy 2025, 19:4957-4966
Published Date: 9 June 2025
Drug Interactions of Imperatorin and Curcumin on Macitentan in vitro and in vivo
Wu H, Liu Q, Shen Y, Qi H, Zhao J, Li Q, Xia H, Xu RA, Shi L
Drug Design, Development and Therapy 2025, 19:3459-3475
Published Date: 29 April 2025
Inhibition of Axitinib on Buspirone Metabolism in vitro and in vivo
Zhang BW, Pang NH, Xu RA, Qu GE, Tang CR
Drug Design, Development and Therapy 2022, 16:2031-2042
Published Date: 30 June 2022
Drug–drug interaction study of imatinib and voriconazole in vitro and in vivo
Lin QM, Xie S, Qiu X, Chen J, Xu RA
Infection and Drug Resistance 2019, 12:1021-1027
Published Date: 30 April 2019
The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro
Xu RA, Gu EM, Liu TH, Ou-yang QG, Hu GX, Cai JP
Infection and Drug Resistance 2018, 11:2129-2135
Published Date: 1 November 2018
The changes of expressive levels of IL-17A, STAT3, and RORγt in different invasive pulmonary aspergillosis mice
Xu LN, Xu RA, Zhang D, Su SS, Xu HY, Wu Q, Li YP
Infection and Drug Resistance 2018, 11:1321-1328
Published Date: 27 August 2018
Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo
He JY, Fang P, Zheng X, Wang CC, Liu TH, Zhang BW, Wen J, Xu RA
Drug Design, Development and Therapy 2018, 12:513-519
Published Date: 9 March 2018
Risk of adverse events with bevacizumab addition to therapy in advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials
Lai XX, Xu RA, Li YP, Yang H
OncoTargets and Therapy 2016, 9:2421-2428
Published Date: 21 April 2016